1. Home
  2. IRON vs EXPO Comparison

IRON vs EXPO Comparison

Compare IRON & EXPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$69.83

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$57.34

Market Cap

2.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
EXPO
Founded
2017
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
IRON
EXPO
Price
$69.83
$57.34
Analyst Decision
Strong Buy
Buy
Analyst Count
11
3
Target Price
$103.18
$88.00
AVG Volume (30 Days)
384.6K
531.4K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
1.87%
EPS Growth
N/A
N/A
EPS
N/A
0.59
Revenue
N/A
$582,014,000.00
Revenue This Year
N/A
$12.75
Revenue Next Year
$283.52
$8.50
P/E Ratio
N/A
$97.02
Revenue Growth
N/A
4.21
52 Week Low
$40.00
$51.91
52 Week High
$99.50
$81.95

Technical Indicators

Market Signals
Indicator
IRON
EXPO
Relative Strength Index (RSI) 54.12 43.05
Support Level $64.48 $51.91
Resistance Level $71.85 $60.42
Average True Range (ATR) 3.26 2.01
MACD 0.04 0.15
Stochastic Oscillator 64.61 45.61

Price Performance

Historical Comparison
IRON
EXPO

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

Share on Social Networks: